The Charles Drew Program in Missouri: a description of a partnership among a blood center and several hospitals to address the care of patients with sickle cell disease

1.Adams RJ, McKie VC, Hsu L et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1988; 339:5-11.10.1056/NEJM199807023390102Search in Google Scholar

2.Vichinsky EP, Luban NLC, Wright E et al. Prospective RBC phenotyping in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41:1086-92.10.1046/j.1537-2995.2001.41091086.xSearch in Google Scholar

3.Osby M, Shulman IA. Phenotypic matching of donor red blood cell units for nonalloimmunized sickle cell disease patients. Arch Pathol Lab Med 2005;129:190-3.10.5858/2005-129-190-PMODRBSearch in Google Scholar

4.Castro O, Sandler SG, Houston-Yu P, and Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-90.10.1046/j.1537-2995.2002.00126.xSearch in Google Scholar

5.Mowbray JF, Gibbings C, Liddel H, et al. Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1985;1:941-3.10.1016/S0140-6736(85)91723-4Search in Google Scholar

6.Klein HG. Immunologic aspects of blood transfusion. Semin Oncol 1994;21:16-20.Search in Google Scholar

7.Waanders MM, Roelen DL, Brand A, Claas FHJ. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Trans Med Rev 2005;19(4):281-7.10.1016/j.tmrv.2005.04.00216214017Search in Google Scholar

8.Persijn GG, Cohen B, Lansbergen Q, et al. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in the Netherlands. Transplantation 1979;28:396-401.10.1097/00007890-197911000-00010392834Search in Google Scholar